Literature DB >> 32143185

The protective effect of trusted dealers against opioid overdose in the U.S.

Jennifer J Carroll1, Josiah D Rich2, Traci C Green3.   

Abstract

BACKGROUND: Opioid overdose has become the leading cause of death among adults between 25 and 54 years old in the U.S. The purpose of this study is to explore the social and relational factors that shape the current opioid overdose epidemic.
METHODS: Between January 2016 and February 2017, adults in Providence, Rhode Island, who use opioids were recruited to complete structured survey and semi-structured interview about the social context of their substance use.
RESULTS: A total of 92 individuals completed a survey and an interview. Of those, 51 individuals (68.6% male, 49.0% white) discussed their relationships with drug suppliers in their interview and were included in this sub-study. Many of these participants indicated that long-term relationships with trusted dealers represent a key strategy for reducing the risk of substance use-related harm due to suppliers' alleged adoption of consumer protection strategies (e.g. refusing to sell fentanyl) and quality assurance measures (e.g. testing batches of drugs for fentanyl prior to sale).
CONCLUSION: Interpersonal relationships between individuals who use drugs and their suppliers strongly influence the risk and protective factors experienced by people who use drugs in today's opioid overdose epidemic. Evidence-based prevention strategies that are based on an awareness of-or even designed to harness-those positive and/or protective relationships that people who use drugs have already constructed for themselves are likely merited.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Opioids; Overdose; Prevention; Social networks; Substance use

Year:  2020        PMID: 32143185      PMCID: PMC7302982          DOI: 10.1016/j.drugpo.2020.102695

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  46 in total

1.  Effect of abuse-deterrent formulation of OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

2.  The Everyday Violence of Hepatitis C Among Young Women Who Inject Drugs in San Francisco.

Authors:  Philippe Bourgois; Bridget Prince; Andrew Moss
Journal:  Hum Organ       Date:  2004-09

Review 3.  The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

Review 4.  The Policy-Driven HIV Epidemic Among Opioid Users in the Russian Federation.

Authors:  Robert Heimer
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

5.  Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization.

Authors:  Julia Brennan; Lisa M Kuhns; Amy K Johnson; Marvin Belzer; Erin C Wilson; Robert Garofalo
Journal:  Am J Public Health       Date:  2012-02-16       Impact factor: 9.308

6.  "One guy goes to jail, two people are ready to take his spot": Perspectives on drug-induced homicide laws among incarcerated individuals.

Authors:  Meghan Peterson; Josiah Rich; Alexandria Macmadu; Ashley Q Truong; Traci C Green; Leo Beletsky; Kimberly Pognon; Lauren Brinkley-Rubinstein
Journal:  Int J Drug Policy       Date:  2019-05-10

7.  The Textures of Heroin: User Perspectives on "Black Tar" and Powder Heroin in Two U.S. Cities.

Authors:  Sarah G Mars; Philippe Bourgois; George Karandinos; Fernando Montero; Daniel Ciccarone
Journal:  J Psychoactive Drugs       Date:  2016-07-20

8.  Impact of South American heroin on the US heroin market 1993-2004.

Authors:  Daniel Ciccarone; George J Unick; Allison Kraus
Journal:  Int J Drug Policy       Date:  2009-02-06

Review 9.  National drug control policy and prescription drug abuse: facts and fallacies.

Authors:  Laxmaiah Manchikanti
Journal:  Pain Physician       Date:  2007-05       Impact factor: 4.965

10.  Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.

Authors:  Saba Rouhani; Ju Nyeong Park; Kenneth B Morales; Traci C Green; Susan G Sherman
Journal:  Harm Reduct J       Date:  2019-06-24
View more
  8 in total

1.  Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs.

Authors:  Leslie D Williams; Eunhye Lee; Carl Latkin; Mary Ellen Mackesy-Amiti; Maggie Kaufmann; Elizabeth Copulsky; Charlie Kaplan; Basmattee Boodram
Journal:  Int J Environ Res Public Health       Date:  2022-04-28       Impact factor: 4.614

2.  Navigating post-eviction drug use amidst a changing drug supply: A spatially-oriented qualitative study of overlapping housing and overdose crises in Vancouver, Canada.

Authors:  Ryan McNeil; Taylor Fleming; Alexandra B Collins; Sandra Czechaczek; Samara Mayer; Jade Boyd
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.492

Review 3.  Naloxone's role in the national opioid crisis-past struggles, current efforts, and future opportunities.

Authors:  Alex S Bennett; Luther Elliott
Journal:  Transl Res       Date:  2021-03-05       Impact factor: 10.171

4.  Practices of care among people who buy, use, and sell drugs in community settings.

Authors:  Gillian Kolla; Carol Strike
Journal:  Harm Reduct J       Date:  2020-05-07

5.  A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes.

Authors:  Joseph J Palamar; İbrahim Sönmez
Journal:  Harm Reduct J       Date:  2022-02-05

6.  Changes in overdose knowledge and attitudes in an incarcerated sample of people living with HIV.

Authors:  Megan Reed; Anne Siegler; Loni P Tabb; Florence Momplaisir; Dorsche Krevitz; Stephen Lankenau
Journal:  Int J Prison Health       Date:  2021-06-15

7.  The discounting of death: Probability discounting of heroin use by fatal overdose likelihood and drug purity.

Authors:  Sean B Dolan; Matthew W Johnson; Kelly E Dunn; Andrew S Huhn
Journal:  Exp Clin Psychopharmacol       Date:  2021-06       Impact factor: 3.492

8.  COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains.

Authors:  Bayla Ostrach; Lesly-Marie Buer; Sam Armbruster; Hillary Brown; Gariann Yochym; Nickolas Zaller
Journal:  J Rural Health       Date:  2020-07-21       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.